Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

XYNTHA® Lyophilized Powder Principal Display Panel (antihemophilic factor [Recombinant])

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Label

0.9% Sodium
Chloride Diluent,
4 mL

Disposable syringe for
drug diluent use with Xyntha®
Antihemophilic Factor
(Recombinant) Sterile,
nonpyrogenic.
Contains no preservatives.

Manufactured for:
Wyeth Pharmaceuticals LLC
A subsidiary of Pfizer Inc
Philadelphia, PA 19101
Manufactured by:
Vetter Pharma-Fertigung GmbH & Co. KG
88212 Ravensburg, Germany
or
Vetter Pharma-Fertigung GmbH & Co. KG
Eisenbahnstrasse 2-4 88085 Langenargen,
Germany

Pfizer

Rx only

US Govt. License No. 3

LOT:

EXP:

PAA134633

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 250 IU Vial Label

250 IU RANGE

xyntha®
Antihemophilic Factor (Recombinant)

No Preservatives. Single Use.

Pfizer

Rx only

For Factor VIII
Replacement

PRINCIPAL DISPLAY PANEL - 250 IU Vial Label

PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU

One single-use vial with 4 mL pre-filled diluent syringe
NDC 58394-012-01

250 IU RANGE

xyntha®

Antihemophilic Factor
(Recombinant)

For Intravenous Administration.

For Factor VIII
Replacement
Therapy Only

Rx only

Manufactured by:
Wyeth Pharmaceuticals LLC
A subsidiary of Pfizer Inc
Philadelphia, PA 19101
US Govt. License No. 3

Pfizer

PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU

PRINCIPAL DISPLAY PANEL - 500 IU Vial Label

500 IU RANGE

xyntha®
Antihemophilic Factor (Recombinant)

No Preservatives. Single Use.

Pfizer

Rx only

For Factor VIII
Replacement

PRINCIPAL DISPLAY PANEL - 500 IU Vial Label

PRINCIPAL DISPLAY PANEL - Kit Carton - 500 IU

One single-use vial with 4 mL pre-filled diluent syringe
NDC 58394-013-01

500 IU RANGE

xyntha®
Antihemophilic Factor
(Recombinant)

For Intravenous Administration.

For Factor VIII
Replacement
Therapy Only

Rx only

Manufactured by:
Wyeth Pharmaceuticals LLC
A subsidiary of Pfizer Inc
Philadelphia, PA 19101
US Govt. License No. 3

Pfizer

PRINCIPAL DISPLAY PANEL - Kit Carton - 500 IU

PRINCIPAL DISPLAY PANEL - 1000 IU Vial Label

1000 IU RANGE

xyntha®
Antihemophilic Factor (Recombinant)

No Preservatives. Single Use.

Pfizer

Rx only

For Factor VIII
Replacement

PRINCIPAL DISPLAY PANEL - 1000 IU Vial Label

PRINCIPAL DISPLAY PANEL - Kit Carton - 1000 IU

One single-use vial with 4 mL pre-filled diluent syringe
NDC 58394-014-01

1000 IU RANGE

xyntha®
Antihemophilic Factor
(Recombinant)

For Intravenous Administration.

For Factor VIII
Replacement
Therapy Only

Rx only

Manufactured by:
Wyeth Pharmaceuticals LLC
A subsidiary of Pfizer Inc
Philadelphia, PA 19101
US Govt. License No. 3

Pfizer

PRINCIPAL DISPLAY PANEL - Kit Carton - 1000 IU

PRINCIPAL DISPLAY PANEL - 2000 IU Vial Label

2000 IU RANGE

xyntha®
Antihemophilic Factor (Recombinant)

No Preservatives. Single Use.

Pfizer

Rx only

For Factor VIII
Replacement

PRINCIPAL DISPLAY PANEL - 2000 IU Vial Label

PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU

One single-use vial with 4 mL pre-filled diluent syringe
NDC 58394-015-01

2000 IU RANGE

xyntha®
Antihemophilic Factor
(Recombinant)

For Intravenous Administration.

For Factor VIII
Replacement
Therapy Only

Rx only

Manufactured by:
Wyeth Pharmaceuticals LLC
A subsidiary of Pfizer Inc
Philadelphia, PA 19101
US Govt. License No. 3

Pfizer

PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event